⌘K

Login Start Free

Home/Filings/4/0001127602-24-015373

4//SEC Filing

Doyle Anthony 4

Accession 0001127602-24-015373

CIK 0000882796other

View on SEC.gov Company Profile

Filed

May 14, 8:00 PM ET

Accepted

May 15, 7:19 AM ET

Size

4.3 KB

Accession

0001127602-24-015373

Insider Transaction Report

Form 4

Period: 2024-05-14

BIOCRYST PHARMACEUTICALS INCBCRX

Chief Financial Officer

Transactions

Purchase
Common Stock
2024-05-14$5.57/sh+36,300$202,191→ 266,744 total

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001808688

Filing Metadata

Form type: 4
Filed: May 14, 8:00 PM ET
Accepted: May 15, 7:19 AM ET
Size: 4.3 KB

View on SEC.gov